Aug 10, 2016, 13:18 PM by Michael Croft

Computerworld | Intel is buying Nervana Systems, a deep learning startup based out of California. The deal speaks volumes about Intel's hopes for the future and where the company is going.

Aug 10, 2016, 09:50 AM by Michael Croft

Bio-IT World | As the Genome Analysis Toolkit, developed at the Broad Institute, continues to serve as the standby for parsing raw genomic data in public projects and major institutions, members of the Broad speak to Bio-IT World about forthcoming updates in GATK4 and new ventures incorporating the toolkit.

Aug 10, 2016, 09:12 AM by Michael Croft

PRINCETON, NJ - Aug 10, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of Phoenix 7

Aug 9, 2016, 09:30 AM by Michael Croft

Fast Company | The school will adopt the Google Genomics cloud platform to improve how it treats patients with cancer, as well as to diagnose children with mysterious, rare diseases.

Aug 8, 2016, 23:59 PM by Michael Croft

LONG ISLAND CITY, NY, UNITED STATES - Aug 8, 2016 - BOC Sciences officially announced that a new category of inhibitors-immune checkpoint inhibitors will began to be provided in system

Aug 8, 2016, 09:20 AM by Michael Croft

Bio-IT World | Software company Repositive aims to make PDX mice, crucial animal models for studying human-like cancers, searchable across vendors by indexing hundreds of different repositories in one platform.

Aug 5, 2016, 12:58 PM by Michael Croft

BAR HARBOR, ME - Aug 5, 2016 - Many lower organisms retain the miraculous ability to regenerate form and function of almost any tissue after injury

Aug 4, 2016, 09:23 AM by Michael Croft

The Seattle Times | Cray CEO Peter Ungaro considers the slowdown in the supercomputer market as "temporary."

Aug 3, 2016, 16:06 PM by Michael Croft

Forbes | Biotech and pharmaceutical industry professionals are busy people like everyone else. But they still find time to read books, especially when schedules slow down a tad during summer. So what are biotech professionals reading, and recommending, these days?

Aug 3, 2016, 12:13 PM by Michael Croft

KANSAS CITY, KS, UNITED STATES - Aug 3, 2016 - Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services

Aug 3, 2016, 10:45 AM by Michael Croft

Bio-IT World Briefs | Editas Medicine and Massachusetts General Hospital (MGH) announced an exclusive licensing agreement this morning, under which Editas can access intellectual property and technology related to high-fidelity Cas9 nucleases and Cas9 PAM variants that will enable the company to address an expanded range of genetically-defined diseases with the potential for enhanced specificity.

Aug 3, 2016, 09:33 AM by Michael Croft

Nature News & Comment | Daniel Himmelstein built a free online network to meld data from 28 public sources on links between drugs, genes, and diseases. Then he spent months chasing legal permission to republish the online data sets.

Aug 3, 2016, 09:32 AM by Michael Croft

PITTSBURGH, PA - Aug 3, 2016 - Curable, a non-profit research accelerator that applies engineering approaches to medicine to develop solutions for rare diseases, today announced that its Chief Executive Officer Lisa Boyette, MD, PhD, has been named a 2016 PharmaVOICE 100 honoree

Aug 2, 2016, 16:00 PM by Michael Croft

WSJ | Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and Allergan PLC, raising the possibility of another huge deal in the health-care industry.

Aug 2, 2016, 10:13 AM by Michael Croft

MUNICH, GERMANY - Aug 2, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of its Clinical Development Offering, making the company the premier provider of comprehensive tissue-based services from discovery to commercialization

Aug 2, 2016, 09:02 AM by Michael Croft

The New York Times | After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.

Aug 1, 2016, 22:21 PM by Michael Croft

STAT | Glaxo and Verily Life Sciences will invest $715 million in Galvani Bioelectronics and hope to win approval for their implantable devices in several years.

Aug 1, 2016, 15:40 PM by Michael Croft

Bio-IT World Briefs | News and product launches from bio IT, clinical IT, and diagnostics technologies include data management installation at Scripps Research Institute and new NGS panels for detection of extremely rare (low-frequency) mutations.

Jul 29, 2016, 12:07 PM by Michael Croft

Computerworld | An industry focus is one of the key factors IBM is betting will set it apart from cloud competitors including Google, Microsoft and Amazon Web Services, IBM's top cloud exec says.

Jul 29, 2016, 05:54 AM by Michael Croft

CAMBRIDGE, UK - Jul 29, 2016 - As the use of whole genome and exome analysis grows it is increasing the workload for the Genomic Medicine Centres